These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 39037592)

  • 1. Advancing Kawasaki Disease Research in the Arab World: Scoping Literature Review Analysis with Emphasis on Giant Coronary Aneurysms.
    Mohamed M; Harahsheh A; Choueiter N; Agha HM; Alrabte H; Abu Al-Saoud SY; Al-Saloos H; Al Senaidi K; Alzyoud R; Al Awadhi Z; Belbouab R; Bouayed K; Bouaziz A; El Ganzoury M; Fitouri Z; Kotby A; Ladj MS; Bekkar MM; Rugige N; Salih AF; Sulaiman M; Dahdah N
    Pediatr Cardiol; 2024 Jul; ():. PubMed ID: 39037592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kawarabi: Administrative Structuring of a Multicenter Research Collaborative to Study Kawasaki Disease in the Arab Countries.
    Arab Y; Harahsheh AS; Dahdah N; El-Kholy N; Abed MY; Abu Al-Saoud SY; Agha HM; Alahmadi F; Alamer SR; Awadhi ZA; Ali S; Ali MT; Alrabte H; Al-Saloos H; Al-Senaidi KS; Alzyoud R; Awidat N; Bouayed K; Bouaziz A; Boukari R; El Ganzoury MM; Elmarsafawy HM; Elrugige N; Fitouri Z; Kotby A; Ladj MS; Bekkar M; Mouawad P; Salih AF; Suleiman M; Choueiter NF
    World J Pediatr Congenit Heart Surg; 2024 Mar; 15(2):177-183. PubMed ID: 37981829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
    Yılmazer MM; Özdemir R; Meşe T; Küçük M; Öner T; Devrim İ; Bayram N; Güven B; Tavlı V
    Turk J Pediatr; 2019; 61(5):648-656. PubMed ID: 32104995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Access to Care and Therapy for Kawasaki Disease in the Arab Countries: A Kawasaki Disease Arab Initiative (Kawarabi) Multicenter Survey.
    Alzyoud R; El-Kholy N; Arab Y; Choueiter N; Harahsheh AS; Aselan AS; Kotby A; Bouaziz A; Salih AF; Abushhaiwia A; Alahmadi F; Agha HM; Elmarsafawy HM; Alrabte H; Al-Saloos H; Boudiaf H; Hijazi I; Bouayed K; Al Senaidi KS; Boughammoura L; Jalal M; Ladj MS; Abu-Shukair ME; ElGanzoury MM; Hammadouche N; Elsamman N; Mouawad P; Boukari R; Benalikhoudja N; Jdour S; Abu Al-Saoud SY; Touri SN; Kammoun T; Fitouri Z; Dahdah N
    Pediatr Cardiol; 2023 Aug; 44(6):1277-1284. PubMed ID: 37126143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incomplete Kawasaki Disease in an Infant: A Case Report and Literature Review.
    Idris I; Awadelkarim AM; Saad E; Dayco J; Beker S
    Cureus; 2022 Feb; 14(2):e22122. PubMed ID: 35308689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic and pulmonary artery aneurysms in incomplete Kawasaki disease.
    Briceno-Medina M; Perez M; Waller BR; Sathanandam S
    J Cardiol Cases; 2016 Jun; 13(6):185-188. PubMed ID: 30546642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etiology and prognosis of non-Kawasaki disease induced coronary aneurysms in children: a retrospective case series study.
    Lin Y; Qi H; Liu Y; Wu H; Li Y; Shi L
    Eur J Pediatr; 2024 Oct; 183(10):4229-4234. PubMed ID: 38990385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High risk of coronary artery aneurysm in Kawasaki disease.
    Mossberg M; Mohammad AJ; Kahn F; Segelmark M; Kahn R
    Rheumatology (Oxford); 2021 Apr; 60(4):1910-1914. PubMed ID: 33150451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kawasaki Disease Arab Initiative [Kawarabi]: Establishment and Results of a Multicenter Survey.
    Arab Y; Choueiter N; Dahdah N; El-Kholy N; Abu Al-Saoud SY; Abu-Shukair ME; Agha HM; Al-Saloos H; Al Senaidi KS; Alzyoud R; Bouaziz A; Boukari R; El Ganzoury MM; Elmarsafawy HM; ELrugige N; Fitouri Z; Ladj MS; Mouawad P; Salih AF; Rojas RG; Harahsheh AS
    Pediatr Cardiol; 2022 Aug; 43(6):1239-1246. PubMed ID: 35624313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A registry study of Kawasaki disease patients with coronary artery aneurysms (KIDCAR): a report on a multicenter prospective registry study three years after commencement.
    Koyama Y; Miura M; Kobayashi T; Hokosaki T; Suganuma E; Numano F; Furuno K; Shiono J; Ebata R; Fuse S; Fukazawa R; Mitani Y
    Eur J Pediatr; 2023 Feb; 182(2):633-640. PubMed ID: 36434403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of coronary artery abnormality in incomplete Kawasaki disease.
    Sonobe T; Kiyosawa N; Tsuchiya K; Aso S; Imada Y; Imai Y; Yashiro M; Nakamura Y; Yanagawa H
    Pediatr Int; 2007 Aug; 49(4):421-6. PubMed ID: 17587261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and Risk Factors for Giant Coronary Artery Aneurysms Identified After Acute Kawasaki Disease.
    Masuda H; Ae R; Koshimizu TA; Matsumura M; Kosami K; Hayashida K; Makino N; Matsubara Y; Sasahara T; Nakamura Y
    Pediatr Cardiol; 2021 Apr; 42(4):969-977. PubMed ID: 33682062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors of medium-giant coronary artery aneurysms in Kawasaki disease.
    Jiang S; Li M; Xu K; Xie Y; Liang P; Liu C; Su Q; Li B
    Pediatr Res; 2024 Jan; 95(1):267-274. PubMed ID: 37670043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Arab region's contribution to global COVID-19 research: Bibliometric and visualization analysis.
    Zyoud SH
    Global Health; 2021 Mar; 17(1):31. PubMed ID: 33766073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affects of "age at diagnosis" on coronary artery lesions in patients with incomplete kawasaki disease.
    Cho MA; Choi YJ; Jung JW
    Korean Circ J; 2010 Jun; 40(6):283-7. PubMed ID: 20589201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheumatology research output in the Arab World: despite the challenges.
    El Hasbani G; Jawad ASM; Uthman I
    Reumatismo; 2022 Dec; 74(3):. PubMed ID: 36580063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol.
    Eleftheriou D; Moraes YC; Purvis C; Pursell M; Morillas MM; Kahn R; Mossberg M; Kucera F; Tulloh R; Standing JF; Swallow V; McCormack R; Herberg J; Levin M; Wan M; Klein N; Connon R; Walker AS; Brogan P
    Trials; 2023 Jan; 24(1):60. PubMed ID: 36703139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of six Z-score formulas based on echocardiography for coronary artery lesions in Kawasaki disease.
    Si X; Hou C; Wang H; Yan W; Tang Y; Hu X; Ni J; Sun L; Lv H; Xu QQ
    Int J Cardiol; 2024 Aug; 409():132102. PubMed ID: 38685457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Giant coronary artery aneurysm associated with Kawasaki disease showing progressive dilation over 30 years.
    Fujioka T; Asakawa N; Suzuki T; Kobayashi J; Takahashi K; Tsuchiya K
    J Cardiol Cases; 2021 Jun; 23(6):281-284. PubMed ID: 34093908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.